These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 9351351
1. Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. Bostom AG, Gohh RY, Tsai MY, Hopkins-Garcia BJ, Nadeau MR, Bianchi LA, Jacques PF, Rosenberg IH, Selhub J. Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1894-900. PubMed ID: 9351351 [Abstract] [Full Text] [Related]
2. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease. de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, Rauwerda JA. Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785 [Abstract] [Full Text] [Related]
3. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. van Guldener C, Janssen MJ, de Meer K, Donker AJ, Stehouwer CD. J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520 [Abstract] [Full Text] [Related]
4. Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients. Han H, Dwyer JT, Selhub J, Jacques PF, Park JH, Kim YS, Bang BK, Bostom AG. J Ren Nutr; 2000 Oct; 10(4):202-7. PubMed ID: 11070148 [Abstract] [Full Text] [Related]
5. Cystatin C is an independent predictor of fasting and post-methionine load total homocysteine concentrations among stable renal transplant recipients. Aras O, Tsai MY, Hanson NQ, Bailey R, Rao G, Hunninghake DB. Clin Chem; 2001 Oct; 47(7):1263-8. PubMed ID: 11427458 [Abstract] [Full Text] [Related]
7. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. van der Griend R, Biesma DH, Haas FJ, Faber JA, Duran M, Meuwissen OJ, Banga JD. J Intern Med; 2000 Sep; 248(3):223-9. PubMed ID: 10971789 [Abstract] [Full Text] [Related]
8. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Bostom AG, Gohh RY, Beaulieu AJ, Nadeau MR, Hume AL, Jacques PF, Selhub J, Rosenberg IH. Ann Intern Med; 1997 Dec 15; 127(12):1089-92. PubMed ID: 9412311 [Abstract] [Full Text] [Related]
10. Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients. Bostom AG, Gohh RY, Beaulieu AJ, Han H, Jacques PF, Selhub J, Dworkin L, Rosenberg IH. Transplantation; 1999 Jul 27; 68(2):257-61. PubMed ID: 10440398 [Abstract] [Full Text] [Related]
11. Betaine and folate status as cooperative determinants of plasma homocysteine in humans. Holm PI, Ueland PM, Vollset SE, Midttun Ø, Blom HJ, Keijzer MB, den Heijer M. Arterioscler Thromb Vasc Biol; 2005 Feb 27; 25(2):379-85. PubMed ID: 15550695 [Abstract] [Full Text] [Related]
12. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance. Ventura P, Panini R, Emiliani S, Salvioli G. Exp Clin Endocrinol Diabetes; 2004 Jan 27; 112(1):44-51. PubMed ID: 14758571 [Abstract] [Full Text] [Related]
13. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH. Atherosclerosis; 1996 Jun 27; 123(1-2):193-202. PubMed ID: 8782850 [Abstract] [Full Text] [Related]
14. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients. Bostom AG, Shemin D, Gohh RY, Beaulieu AJ, Bagley P, Massy ZA, Jacques PF, Dworkin L, Selhub J. Kidney Int Suppl; 2001 Feb 27; 78():S246-52. PubMed ID: 11169020 [Abstract] [Full Text] [Related]
15. B-vitamins, homocysteine and gene polymorphism in adults with fasting or post-methionine loading hyperhomocysteinemia. Cheng CH, Huang YC, Chen FP, Chou MC, Tsai TP. Eur J Nutr; 2008 Dec 27; 47(8):491-8. PubMed ID: 18979127 [Abstract] [Full Text] [Related]
16. Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens. van der Griend R, Biesma DH, Banga JD. Vasc Med; 2002 Feb 27; 7(1):29-33. PubMed ID: 12083731 [Abstract] [Full Text] [Related]
17. Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. Han H, Dwyer JT, Selhub J, Jacques PF, Houser RF, Park JH, Kim YS, Bang BK, Kim S, Jung KA, Chang YK, Bostom AG. J Ren Nutr; 2001 Jul 27; 11(3):149-54. PubMed ID: 11466665 [Abstract] [Full Text] [Related]
18. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran. Monfared A, Azimi SZ, Kazemnezhad E, Khosravi M, Lebadi M, Mirzajani E, Ashtiani MN. Transplantation; 2014 Jul 15; 98(1):66-71. PubMed ID: 24978036 [Abstract] [Full Text] [Related]
19. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G. Metabolism; 2001 Dec 15; 50(12):1466-71. PubMed ID: 11735095 [Abstract] [Full Text] [Related]
20. Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Bostom AG. Arterioscler Thromb Vasc Biol; 2001 May 15; 21(5):849-51. PubMed ID: 11348885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]